Smartphone App for Taking Images of Conjunctivae

Sponsor
London School of Hygiene and Tropical Medicine (Other)
Overall Status
Terminated
CT.gov ID
NCT03997487
Collaborator
National Institute for Medical Research, Tanzania (Other), Federal Minstry of Health of Ethiopia (Other), Jos University Teaching Hospital (Other), University College London Hospitals (Other), RTI International (Other), Sightsavers (Other), World Health Organization (Other), Pan American Health Organization (Other)
125
1
1
4
951.2

Study Details

Study Description

Brief Summary

Trachomatous inflammation-follicular (TF) is diagnosed by looking for clinical signs of infection of everted eyelids (conjunctivae) of children.

The overall objective of this project is to develop a smartphone application and assess its acceptability and feasibility.

Fieldwork will take place during routine Tropical Data trainings and population-based prevalence surveys supported by Tropical Data.

Healthy adult volunteers in London will have photos of their conjunctivae taken to develop the app initially, with iterative improvements to the app based on image quality achieved. For fieldwork, images of the conjunctivae of children will be have photos of their conjunctivae taken with a digital single lens reflex (DSLR) camera and the newly developed smartphone app. Grading of the photos will be compared with field grading, to compare grading agreement, to assess utility for supervision, quality assurance and training purposes.

Condition or Disease Intervention/Treatment Phase
  • Other: TOFTEE
N/A

Detailed Description

The investigators want to see whether it would be possible to take photos using Android smartphones, routinely used in trachoma surveys for collecting data, for quality assurance, supervision and training purposes. The investigators will develop an app in the United Kingdom (UK) by taking photos of the conjunctivae of healthy adult volunteers to iteratively improve the quality of images based on the image metadata and review by trachoma experts. The app will then be field tested, and trachoma grading based on the app photos, DSLR photos, and clinical grading, compared. Any management (treatment) will be based on routine clinical diagnosis only - the images are for research purposes only. The investigators will also ask participants for their views on acceptability of having photos of conjunctivae taken with the phone, and conduct a cost-consequences analysis of potential implementation of the app in routine trachoma surveys.

Objectives and approach:

2.1 To develop a mobile phone application to capture images of everted eyelids (conjunctivae) of children being examined as part of the Tropical Data field inter-grader agreement (IGA) test, or sampled as part of trachoma prevalence surveys.

2.2 To evaluate the quality of the mobile phone application images compared with field grading and DSLR images.

2.3 To assess the acceptability and feasibility of a mobile phone application for photographing everted eyelids (conjunctivae) from children being examined as part of the Tropical Data IGA test, or sampled as part of trachoma prevalence surveys.

2.4 To conduct a cost-consequences analysis of setting up an infrastructure for capturing and transmitting images in order to make the system economically viable.

Study Design

Study Type:
Interventional
Actual Enrollment :
125 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Developing and Evaluating Trachoma Diagnosis Training Tools in Preparation for the Trachoma Elimination Endgame: Development of a Smartphone Application to Capture Quality Images of Everted Eye Lids and Assessment of Its Acceptability and Feasibility
Actual Study Start Date :
Jul 8, 2019
Actual Primary Completion Date :
Jul 12, 2019
Actual Study Completion Date :
Jul 12, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Children examined

All children examined for clinical signs of trachoma will be invited to participate to have photos of conjunctivae taken with the TOFTEE smartphone app and a DSLR camera.

Other: TOFTEE
Smartphone app for taking quality images of conjunctivae

Outcome Measures

Primary Outcome Measures

  1. TOols For Trachoma Elimination Endgame (TOFTEE) app image quality [30 minutes]

    Photo quality will be assessed by trachoma grading experts. The technical parameters such as lighting, resolution, focus, etc. will be assessed using objective software or extracted from the photograph metadata.

  2. Kappa score of TOFTEE image compared with field grading [5 minutes]

    Concordance in diagnosis of trachoma between field grading and app image

  3. Kappa score of TOFTEE image compared with DSLR grading [5 minutes]

    Concordance in diagnosis of trachoma between app image and DSLR image

  4. Kappa score of DSLR image compared with field grading [5 minutes]

    Concordance in diagnosis of trachoma between field grading and DSLR image

Secondary Outcome Measures

  1. Association (reported as proportions, unadjusted and adjusted odds ratios) between child characteristics and TOFTEE image quality [15 minutes]

    Association (reported as proportions, unadjusted and adjusted odds ratios) between child characteristics acceptable photo quality

  2. Acceptability and feasibility of TOFTEE app in communities [45 minutes]

    Common themes, as determined through thematic analysis of focus group discussion transcripts, relating to acceptability and feasibility of TOFTEE app in communities

  3. Acceptability and feasibility of TOFTEE app in Tropical Data system [45 minutes]

    Common themes, as determined through thematic analysis of focus group discussion transcripts, relating to acceptability and feasibility of TOFTEE app as part of the Tropical Data system

  4. Cost of TOFTEE app implementation [5 days]

    Cost (overall and broken down by category: personnel; supplies; transit; telecommunications) of TOFTEE app implementation into the Tropical Data system

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Objectives 2.1 and 2.2:
  • For the London-based app development, any eligible healthy adult who provides written informed consent will be eligible.

  • For the field-based app development, any child aged 1-9 years being examined as part of the Tropical Data IGA test, or sampled as part of trachoma prevalence surveys, and for whom written informed consent has been provided by a guardian, will be eligible.

Objective 2.3:
  • All Tropical Data trainers and trainees attending the Tropical Data (initial and refresher) training events and who provide written informed consent, will be eligible.

  • Community leaders and children's guardians who provide written informed consent will be eligible.

Exclusion Criteria:
  • For each of the objectives, if the inclusion criteria are not fulfilled, the participant will not be eligible to participate.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Arusha region Arusha Tanzania

Sponsors and Collaborators

  • London School of Hygiene and Tropical Medicine
  • National Institute for Medical Research, Tanzania
  • Federal Minstry of Health of Ethiopia
  • Jos University Teaching Hospital
  • University College London Hospitals
  • RTI International
  • Sightsavers
  • World Health Organization
  • Pan American Health Organization

Investigators

  • Principal Investigator: Emma Harding-Esch, LSHTM

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
London School of Hygiene and Tropical Medicine
ClinicalTrials.gov Identifier:
NCT03997487
Other Study ID Numbers:
  • 2019-KEP-284 - 2
First Posted:
Jun 25, 2019
Last Update Posted:
Aug 22, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 22, 2022